Abstract

Skin diseases and lesions can be ambiguous to recognize due to the similarity of lesions and enhanced imaging features. In this study, we compared three cutting-edge deep learning frameworks for dermoscopic segmentation: U-Net, SegAN, and MultiResUNet. We used a dermoscopic dataset including detailed lesion annotations with segmentation masks to help train and evaluate models on the precise localization of melanomas. SegAN is a special type of Generative Adversarial Network (GAN) that introduces a new architecture by adding generator and discriminator steps. U-Net has become a common strategy in segmentation to encode and decode image features for limited data. MultiResUNet is a U-Net-based architecture that overcomes the insufficient data problem in medical imaging by extracting contextual details. We trained the three frameworks on colored images after preprocessing. We added incremental Gaussian noise to measure the robustness of segmentation performance. We evaluated the frameworks using the following parameters: accuracy, sensitivity, specificity, Dice and Jaccard coefficients. Our accuracy results show that SegAN (92%) and MultiResUNet (92%) both outperform U-Net (86%), which is a well-known segmentation framework for skin lesion analysis. MultiResUNet sensitivity (96%) outperforms the methods in the challenge leaderboard. These results suggest that SegAN and MultiResUNet are more resistant techniques against noise in dermoscopic segmentation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.